2013
DOI: 10.1134/s0006297913070122
|View full text |Cite
|
Sign up to set email alerts
|

Development of approaches to creation of experimental test system for evaluation of antigenic activity of synthetic oligosaccharide ligands related to fragments of the Streptococcus pneumoniae type 14 capsular polysaccharide

Abstract: A conjugate of a synthetic hexasaccharide fragment of the Streptococcus pneumoniae type 14 capsular polysaccharide with bovine serum albumin (BSA) has been prepared. The antigenic activity and specificity of this conjugate are comparable with those of natural antigens of S. pneumoniae type 14. The data suggest that the resulting synthetic conjugate can be used as a coating antigen in an experimental test system (based on enzyme immunoassay) for evaluating the antigenic activity and specificity of synthetic oli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Ab titers were measured by enzyme-linked immunosorbent assay (ELISA) from individual blood samples of 6–12 mice/dose (the results of two experiments), or from pooled sera of 6 mice/conjugate, as previously described (27). To prepare for the titer assays, flat-bottom plates (Biomedicals, Russia) were coated with S. pneumoniae type 14 bacterial CP (1 µg/well) or synthetic CP (0.5 µg/well).…”
Section: Methodsmentioning
confidence: 99%
“…Ab titers were measured by enzyme-linked immunosorbent assay (ELISA) from individual blood samples of 6–12 mice/dose (the results of two experiments), or from pooled sera of 6 mice/conjugate, as previously described (27). To prepare for the titer assays, flat-bottom plates (Biomedicals, Russia) were coated with S. pneumoniae type 14 bacterial CP (1 µg/well) or synthetic CP (0.5 µg/well).…”
Section: Methodsmentioning
confidence: 99%
“…The HS conjugate [β-Gal-(1 → 4)-β-Glc-(1 → 6)-[β-Gal-(1 → 4)]-β-GlcNAc-(1 → 3)-β-Gal-(1 → 4)-β-Glc-O-spacer] 15 -BSA was prepared by the squarate method and contained, according to MALDI-TOF data, on average, 15 HS residues as previously described ( 30 , 31 ) and 19% carbohydrates on a dry weight basis (Figure 1 ). The BSA is often used as a protein carrier to design immunogenic GCs and biomolecular systems ( 32 ) of other types.…”
Section: Methodsmentioning
confidence: 99%
“…A booster immunization of GC + AL was carried out on d 92. Anti-PS IgG and subisotype (IgG1, IgG2a, IgG2b, IgG3) levels were determined by the enzyme-linked immunosorbent assay (ELISA) as previously described ( 30 ). Specifically, flat-bottom plates (Biochemicals, Russia) were coated with a PS preparation from S. pneumoniae type 14 (1 μg/well).…”
Section: Methodsmentioning
confidence: 99%
“…In the framework of our research program aiming at the design of carbohydrate pneumococcal vaccines based on synthetic oligosaccharide ligands structurally related to the CPs, we synthesized a set of oligosaccharides representing fragments of the CPs of serotypes 3 and 14 ( Sukhova et al, 2014 ; Tsvetkov et al, 2017 ) and investigated their immunological properties ( Kurbatova et al, 2013 ; Akhmatova et al, 2016 ; Kurbatova et al, 2016 ; Kurbatova et al, 2017 ; Kurbatova et al, 2020 ). Recently, we published the synthesis of spacer-armed pseudotetrasaccharide 1 corresponding to a repeating unit of the S. pneumoniae type 6B polysaccharide ( Sukhova et al, 2018 ).…”
Section: Introductionmentioning
confidence: 99%